Zinc Patents (Class 424/641)
  • Publication number: 20140027358
    Abstract: A system for dispensing water treatment compositions into a pool, spa, or other body of water is disclosed, which system provides a visible cue that the water treatment is properly dispersing and also provides a visible cue when the desired amount of water treatment has been dispensed. The system comprises a dispenser and the water treatment composition contained within the body of the dispenser, which dispenser and which system provides a readily visual cue that when the water treatment dose has been fully, or in some cases mostly or partially dispersed. For example, the dispenser sinks when fully dosed and resurfaces when empty, and in particular embodiments the water treatment comprises a means for generating visible gas bubbles and/or producing a color stream as the treatment dissolves.
    Type: Application
    Filed: April 1, 2013
    Publication date: January 30, 2014
    Applicant: CHEMTURA CORPORATION
    Inventors: CurtIS Sayre, Zach Hansen, David Rouse, Anna Florine McLeroy
  • Publication number: 20140023656
    Abstract: The present invention provides a medicinal agent and a method for each of various testing or the like, which enable the treatment and prevention, particularly preventive treatment, of Th3 march-related diseases. The present invention also provides a pharmaceutical composition for treating and/or preventing Th3 march-related diseases, which comprises zinc, calcium and phosphorus and additionally comprises pumpkin seeds and corn silk, and which preferably can activate the DNA repairing ability of a zinc finger, particularly the ability of repairing defect or mutation of DNA for a filaggrin gene, of a zinc finger.
    Type: Application
    Filed: September 26, 2011
    Publication date: January 23, 2014
    Applicant: BioLT CO., LTD.
    Inventors: Masato Kuwabara, Yasuhiko Kojima, Takashi Oyamada, Michio Honjo, Kazuko Uno, Yukio Yajima, Akina Kuwabara
  • Publication number: 20140004168
    Abstract: A biocidal glass composition for use in roofing applications can include glass doped with at least one biocidal agent that includes about 0.01 wt. % to about 50 wt. % of a total weight % of the biocidal glass composition. The biocidal glass composition can be included in a coating on a base particle of a roofing granule. Further included is a process of forming the roofing granule.
    Type: Application
    Filed: March 15, 2013
    Publication date: January 2, 2014
    Inventors: Pierre-Olivier Petit, Keith C. Hong, Gregory F. Jacobs, Kamila Plevacova
  • Publication number: 20130345061
    Abstract: A water-in-oil (w/o) or oil-in-water (o/w) emulsion composed of an oily phase including one or more oils of crude or refined vegetable origin, and at least one non-ionic and/or anionic emulsifying surfactant, and of an aqueous phase, the aqueous phase including at least one phyllosilicate, as a phytopharmaceutical adjuvant intended to be mixed with at least one phytopharmaceutical active agent or as a phytopharmaceutical product with mechanical action. A phytopharmaceutical composition including an active agent and also a phytopharmaceutical adjuvant as defined above, and a method of treating plants with the composition.
    Type: Application
    Filed: February 9, 2012
    Publication date: December 26, 2013
    Applicant: MAXEL INDUSTRIES
    Inventors: Roman Gerusz, Antoine Vanlaer
  • Publication number: 20130337085
    Abstract: The subject matter of the present invention is in particular the use of an amino acid sequence of IDE, or of an analogue or fragment thereof, or of at least one nucleic acid sequence encoding this sequence, as a biomarker, or as an active agent, with regard to a dandruff condition of the scalp.
    Type: Application
    Filed: December 12, 2011
    Publication date: December 19, 2013
    Applicant: L'oreal
    Inventors: Caroline Delattre, Philemon Sirven, Dominique Bernard
  • Publication number: 20130337086
    Abstract: The present disclosure generally relates to the medical use of compositions comprising a mineral salt and a sulfonic acid for prevention and/or treatment of one or more mucosal diseases, disorders, or conditions or one or more dermal diseases, disorders, or conditions.
    Type: Application
    Filed: March 12, 2013
    Publication date: December 19, 2013
    Applicant: BMG PHARMA LLC
    Inventor: BMG PHARMA LLC
  • Patent number: 8609121
    Abstract: Provided is a photocatalytic composition comprising zinc (Zn) doped titanium dioxide (TiO2) nanoparticles, wherein the ratio of titanium dioxide nanoparticles to zinc is from about 5 to about 150. The photocatalytic composition absorbs electromagnetic radiation in a wavelength range from about 200 nm to about 500 nm, and the absorbance of light of wavelengths longer than about 450 nm is less than 50% the absorbance of light of wavelengths shorter than about 350 nm. Further provided is a method for treating or preventing microbial diseases and infestations in a plant and a method for increasing crop yield of a plant by applying the photocatalytic compositions taught herein to the surface of a plant. Also provided is a method for treating microbial diseases on a surface by applying the photocatalytic compositions taught herein to a surface illuminated by artificial light.
    Type: Grant
    Filed: May 3, 2012
    Date of Patent: December 17, 2013
    Inventors: Stewart B. Averett, Devron R. Averett
  • Publication number: 20130309320
    Abstract: The present invention relates to combinations of 4-bromo-2-(4-chloro-phenyl)-5-(trifluoromethyl)-1H-pyrrole-3-carbonitrile, or a salt thereof, and copper or zinc compounds which provide an improved protecting effect against fouling organisms. More particularly, the present invention relates to compositions comprising a combination of 4-bromo-2-(4-chlorophenyl)-5-(trifluoromethyl)-1H-pyrrole-3-carbonitrile, or a salt thereof, together with one or more copper or zinc compounds selected from Cu2O, Cu(OH)2, CuSO4, copper pyrithione, CuSCN, CuCO3, ZnO, ZnCl2, ZnSO4, zineb, and zinc pyrithione; in respective proportions to provide a synergistic effect against fouling organisms and the use of these compositions for protecting materials against fouling organisms. This invention thus relates to the field of protection of materials, such as underwater objects, protection of wood, wood products, biodegradable materials and coatings.
    Type: Application
    Filed: July 24, 2013
    Publication date: November 21, 2013
    Applicant: Janssen Pharmaceutica, NV
    Inventor: Tony Mathilde Jozef Kempen
  • Patent number: 8586629
    Abstract: This invention is based on the observed oxidative stress and increased risk on cardiovascular diseases in subjects with increased lipid peroxidation, in particular with women using oral contraceptives and in hormone replacement therapies. The invention provides compositions and combinations, particularly useful in preventing and or reducing the increased lipid peroxidation in subjects in need thereof. These compositions are based on the synergistic combination of zinc and/or a hydroxyl radical scavenger in reducing lipid peroxidation.
    Type: Grant
    Filed: August 6, 2010
    Date of Patent: November 19, 2013
    Assignee: Probiox SA
    Inventor: Donat Eugene H. De Groote
  • Publication number: 20130295155
    Abstract: Time-release algae-resistant roofing granules have a base particle including an algaecide and an outer coating layer including another algaecide. The at least two algaecides are released over different predetermined periods. The outer layer protects the base particle from exposure to the environment for a predetermined period, then fails catastrophically so that the interior algaecide can be released.
    Type: Application
    Filed: July 1, 2013
    Publication date: November 7, 2013
    Inventors: Husnu M. Kalkanoglu, Keith C. Hong, Joong Youn Kim, Ming Liang Shiao
  • Publication number: 20130295150
    Abstract: The invention features a galvanic particulate including a first conductive material and a second conductive material, wherein both the first conductive material and the second conductive material are exposed on the surface of the particulate, wherein the particle size of the particulate is from about 10 nanometers to about 100 micrometers, wherein the second conductive material comprises from about 0.01 percent to about 10 percent, by weight, of the total weight of the particulate, and wherein the difference of the standard potentials of the first conductive material and the second conductive material is at least about 0.2 V.
    Type: Application
    Filed: April 25, 2013
    Publication date: November 7, 2013
    Applicant: Johnson & Johnson Consumer Companies, Inc.
    Inventor: Johnson & Johnson Consumer Companies, Inc.
  • Publication number: 20130287863
    Abstract: The present invention relates to an antimicrobial composition comprising an isothiazolinone, such as 1,2-benzisothiazolin-3-one, and a zinc compound selected from zinc salts, zinc oxides, zinc hydroxides or combinations thereof. Useful zinc salts include for example, oxides, sulfates, chlorides, and combinations thereof. In use, the zinc from the zinc compound enhances the antimicrobial activity to the isothiazolin-containing composition. This enhancement permits achieving the desired antimicrobial activity at a lower usage rate than is achieved using the isothiazolinone in the absence of the zinc compound. The antimicrobial composition can also contain co-biocides, such as pyrithiones, including zinc pyrithione or copper pyrithione.
    Type: Application
    Filed: March 26, 2013
    Publication date: October 31, 2013
    Inventors: Nicholas Edward Thompson, Malcom Greenhalgh, Fitzgerald Clarke
  • Patent number: 8568791
    Abstract: The present invention herein provides antibacterial zeolite particles whose ion-exchangeable ions have completely or partially been replaced with silver ions and zinc ions, wherein the ratio (A/B) of the silver ion concentration (A) to the zinc ion concentration (B) in the antibacterial zeolite particles increases in the direction along the depth of each zeolite particle. The antibacterial zeolite particles show excellent discoloration-resistant characteristics, while maintaining their excellent antibacterial activities. Accordingly, the antibacterial zeolite particles can suitably be applied to all sorts of products that are required to have antibacterial properties.
    Type: Grant
    Filed: May 17, 2007
    Date of Patent: October 29, 2013
    Assignee: Sinanen Zeomic Co., Ltd.
    Inventors: Yasuo Kurihara, Kumiko Miyake, Masashi Uchida
  • Patent number: 8562860
    Abstract: A method for activating hydrogen molecules dissolved in water and stabilizing the concentration of the hydrogen molecules is provided. The method for activating and stabilizing hydrogen molecules dissolved in water is characterized by allowing hydrogen ions to coexist with the hydrogen molecules.
    Type: Grant
    Filed: July 5, 2007
    Date of Patent: October 22, 2013
    Assignee: Spring Co., Ltd.
    Inventor: Osao Sumita
  • Patent number: 8563538
    Abstract: Methods are provided for reducing copper values for, by way of example, treating, preventing or ameliorating tissue damage such as, for example, tissue damage that may be caused by (i) disorders of the heart muscle (for example, cardiomyopathy or myocarditis) such as idiopathic cardiomyopathy, metabolic cardiomyopathy which includes diabetic cardiomyopathy, alcoholic cardiomyopathy, drug-induced cardiomyopathy, ischemic cardiomyopathy, and hypertensive cardiomyopathy, (ii) atheromatous disorders of the major blood vessels (macrovascular disease) such as the aorta, the coronary arteries, the carotid arteries, the cerebrovascular arteries, the renal arteries, the iliac arteries, the femoral arteries, and the popliteal arteries, (iii) toxic, drug-induced, and metabolic (including hypertensive and/or diabetic disorders of small blood vessels (microvascular disease) such as the retinal arterioles, the glomerular arterioles, the vasa nervorum, cardiac arterioles, and associated capillary beds of the eye, the kidney
    Type: Grant
    Filed: February 28, 2011
    Date of Patent: October 22, 2013
    Assignee: Philera New Zealand Limited
    Inventors: Garth J. S. Cooper, John R. Baker
  • Publication number: 20130273176
    Abstract: Methods and compositions for promoting sleep in an animal are provided. In a general aspect, a sleep promoting amount of astaxanthin and a sleep promoting amount of melatonin are administered in conjunction to an animal. The astaxanthin can be administered in an amount ranging from about 0.1 to about 60 mg/kg/body weight of the animal. The melatonin can be administered in an amount ranging from about U. I to about 40 mg/kg/body weight of the animal. The method can further comprise administering in conjunction a sleep promoting amount of zinc to the animal. The zinc can be administered in an amount ranging from about 10 to about 100 mg/kg/body weight of the animal.
    Type: Application
    Filed: November 14, 2011
    Publication date: October 17, 2013
    Applicant: Nestec SA
    Inventor: Brian Michael Zanghi
  • Patent number: 8557293
    Abstract: A sunscreen composition for application for plants comprises Titanium Dioxide (TiO2), Zinc Oxide (ZnO), Silicon Dioxide (SiO2), a surfactant, wetting agent, dispersant (SWD) and water. The composition forms a suspension concentrate when combined that when diluted in water provides a solution that provides uniform coverage using convention spraying equipment. A method of protecting plants including turfgrass from ultraviolet radiation, heat stress and/or sunburn comprises combining TiO2, ZnO, SiO2, SWD and water to form a suspension concentrate. The suspension concentrate is then diluted in water and applied to an area in which sun protection is desired.
    Type: Grant
    Filed: August 26, 2010
    Date of Patent: October 15, 2013
    Inventor: Scott May
  • Patent number: 8551513
    Abstract: A scaffold for implantation into a mammal to facilitate vessel growth in repair, regeneration, and/or proliferation of bodily tissue, where the scaffold is based on a borate, silicate, or phosphate, glass-former and is biodegradable upon implantation in mammals. The scaffold includes one or more trace elements from the group consisting of Cu, F, Fe, Mn, Mo, Ni, Si, Sr, and Zn which are released into the host to support vessel growth. A method involves implantation of such scaffolds.
    Type: Grant
    Filed: October 1, 2012
    Date of Patent: October 8, 2013
    Assignee: The Curators of the University of Missouri
    Inventors: Steven B. Jung, Delbert E. Day
  • Patent number: 8551533
    Abstract: An adjuvant composition is provided which comprises: (a) at least one water-soluble electrolyte; (b) at least one electrolyte-tolerant surfactant; (c) antifoam component which is at least one mixture selected from the group consisting of (1) at least one branched silicone resin (i), at least one silicone fluid (ii), at least one particulate metal oxide (iii) and, optionally, at least one catalyst (iv) for catalyzing the condensation of siloxy groups, (2) the equilibration reaction product of mixture (1), and (3) mixture (1) in which at least a portion of particulate metal oxide (iii) is pre-hydrophobized; (d) optionally, at least one additional bioinert material; and, (e) water.
    Type: Grant
    Filed: May 9, 2011
    Date of Patent: October 8, 2013
    Assignee: Momentive Performance Materials Inc.
    Inventors: William L Brown, Kalman Koczo, George A Policello
  • Patent number: 8546423
    Abstract: Disclosed herein are formulations of fluoroquinolones suitable for aerosolization and use of such formulations for aerosol administration of fluoroquinolone antimicrobials for the treatment of pulmonary bacterial infections. In particular, inhaled levofloxacin specifically formulated and delivered for bacterial infections of the lungs is described. Methods include inhalation protocols and manufacturing procedures for production and use of the compositions described.
    Type: Grant
    Filed: October 22, 2009
    Date of Patent: October 1, 2013
    Assignee: MPEX Pharmaceuticals, Inc.
    Inventors: Mark W. Surber, Keith A. Bostian, Michael N. Dudley, Olga Lomovskaya, David C. Griffith
  • Publication number: 20130243885
    Abstract: The invention concerns a three component system comprising surface-active substances, vitamins and metal ions for efficient destruction and removal of contaminating proteins, nucleic acids and microorganisms from surfaces like for example laboratory benches, floors, equipment and instruments. These non-corrosive and non-toxic solutions for removal of proteins, nucleic acids and microorganisms are applied by spraying, rubbing or immersion of contaminated surfaces thereby destroying, solubilizing inactivating and removing proteins and nucleic acids. In that way also microorganisms are killed with high efficiency and at the same time all genetic information is inactivated.
    Type: Application
    Filed: April 21, 2013
    Publication date: September 19, 2013
    Applicant: MULTIBIND BIOTEC GMBH
    Inventors: Thomas Lisowsky, Karlheinz Esser, Richard Lisowsky
  • Patent number: 8535710
    Abstract: A method for treating a wound, and a dressing for wound care management comprising a three-dimensional body of glass-based fibers comprising one or more glass-formers selected from the group consisting of P2O5, SiO2, and B2O3; at least about 25 wt % of the fibers have a diameter between about 200 nm and about 4000 nm, and a length:width aspect ratio of at least about 10. In another form, the glasses are in the form of particles in an ointment or cream applied to a wound. In yet other forms the glasses are employed as fibers formed into sutures for closing a wound, or as particles in a surgical glue for closing a wound.
    Type: Grant
    Filed: April 9, 2012
    Date of Patent: September 17, 2013
    Assignee: The Curators of the University of Missouri
    Inventors: Steven B. Jung, Delbert E. Day
  • Patent number: 8535659
    Abstract: The present invention relates to different nutritional supplements to be administered to, or taken by, pregnant women during the first, second and third trimesters of pregnancy.
    Type: Grant
    Filed: May 21, 2009
    Date of Patent: September 17, 2013
    Assignee: Argent Development Group, LLC
    Inventors: John C. Morrison, Kenneth R. Greathouse
  • Patent number: 8535660
    Abstract: The present invention relates to different nutritional supplements to be administered to, or taken by, pregnant women during the first, second and third trimesters of pregnancy.
    Type: Grant
    Filed: November 7, 2011
    Date of Patent: September 17, 2013
    Assignee: Argent Development Group, LLC
    Inventors: John C. Morrison, Kenneth R. Greathouse
  • Patent number: 8524735
    Abstract: Disclosed herein are formulations of fluoroquinolones suitable for aerosolization and use of such formulations for aerosol administration of fluoroquinolone antimicrobials for the treatment of pulmonary bacterial infections. In particular, inhaled levofloxacin specifically formulated and delivered for bacterial infections of the lungs is described. Methods include inhalation protocols and manufacturing procedures for production and use of the compositions described.
    Type: Grant
    Filed: October 22, 2009
    Date of Patent: September 3, 2013
    Assignee: MPEX Pharmaceuticals, Inc.
    Inventors: Mark W. Surber, Keith A. Bostian, Michael N. Dudley, Olga Lomovskaya, David C. Griffith
  • Patent number: 8524734
    Abstract: Disclosed herein are formulations of fluoroquinolones suitable for aerosolization and use of such formulations for aerosol administration of fluoroquinolone antimicrobials for the treatment of pulmonary bacterial infections. In particular, inhaled levofloxacin specifically formulated and delivered for bacterial infections of the lungs is described. Methods include inhalation protocols and manufacturing procedures for production and use of the compositions described.
    Type: Grant
    Filed: October 22, 2009
    Date of Patent: September 3, 2013
    Assignee: MPEX Pharmaceuticals, Inc.
    Inventors: Mark W. Surber, Keith A. Bostian, Michael N. Dudley, Olga Lomovskaya, David C. Griffith
  • Patent number: 8512725
    Abstract: There is provided a method for treating a fluid with an anti-microbial agent comprising the steps of: (a) contacting the fluid with a solid material containing an anti-microbial agent; and, (b) abrading an interface of the solid material and removing particles therefrom and exposing an underlying surface of the solid material to the fluid, thereby facilitating release of the antimicrobial agent of the underlying surface of the solid material and/or the removed particles into the fluid. The solid material comprises an anti-microbial agent dispersed and/or embedded in a solid carrier. Typically, the anti-microbial agent is one or more of a metal, metal oxide, metal compound, metal salt, metal-ligand complex or derivatives thereof based on silver, copper and zinc.
    Type: Grant
    Filed: September 7, 2005
    Date of Patent: August 20, 2013
    Assignee: Bacstop Corporation Pty Ltd
    Inventors: Allen Roland Parsons, Donald William Atkinson
  • Publication number: 20130209823
    Abstract: The present invention provides a method of protecting wood or other celiulosic material from decay by copper-tolerant fungi, and wood preservative formulations for use in the same. The wood preservative formulations comprise a biocidal metal compound, a 1,2,4-triazole and a didecyl quaternary ammonium cation. Didecyldimethyl quaternary ammonium compounds are particularly preferred.
    Type: Application
    Filed: June 21, 2011
    Publication date: August 15, 2013
    Applicant: ARCH TIMBER PROTECTION LIMITED
    Inventors: Craig Andrew Mars, David Grindon Cantrell, Kevin Hughes, Andrew Stewart Hughes
  • Publication number: 20130209576
    Abstract: Disclosed herein are compositions and corresponding methods for treating contaminated water and/or contaminable surfaces in order to kill, or otherwise reduce to non-harmful levels the survival of, biological contaminants resident therein and thereon, respectively.
    Type: Application
    Filed: January 10, 2013
    Publication date: August 15, 2013
    Applicant: SAFEWATERDROPS
    Inventor: SAFEWATERDROPS
  • Patent number: 8507004
    Abstract: Systems and methods for use of magnesium hydroxide, either directly or through one or more precursors, doped with a divalent or trivalent metal cation, for removing arsenic from drinking water, including water distribution systems. In one embodiment, magnesium hydroxide, Mg(OH)2 (a strong adsorbent for arsenic) doped with a divalent or trivalent metal cation is used to adsorb arsenic. The complex consisting of arsenic adsorbed on Mg(OH)2 doped with a divalent or trivalent metal cation is subsequently removed from the water by conventional means, including filtration, settling, skimming, vortexing, centrifugation, magnetic separation, or other well-known separation systems. In another embodiment, magnesium oxide, MgO, is employed, which reacts with water to form Mg(OH)2. The resulting Mg(OH)2 doped with a divalent or trivalent metal cation, then adsorbs arsenic, as set forth above. The method can also be used to treat human or animal poisoning with arsenic.
    Type: Grant
    Filed: December 17, 2008
    Date of Patent: August 13, 2013
    Assignee: Sandia Corporation
    Inventors: Robert C. Moore, Kathleen C. Holt-Larese, Ranko Bontchev
  • Patent number: 8491812
    Abstract: Compositions for cleaning, sanitizing and maintaining contained bodies of water such as swimming pools, wading pools, fountains, ornamental ponds, etc. The compositions include pre-determined percentages of hydrates of copper sulfate, zinc sulfate, and aluminum sulfate by weight. The composition uses hydrates of copper, zinc and aluminum sulfates instead of the anhydrous metal salts. The hydrate forms can be mined, transported, processed, mixed and packaged without climate controlled conditions necessary for anhydrous metal salts. Hydrates in the composition can gain additional water molecules or lose attached water molecules during manufacture, processing, transportation or use of the composition, without negatively affecting the physical format of the composition or reducing its effectiveness. The compositions reduce amounts of chlorine and an amount of labor associated with the cleaning, sanitization and maintenance of contained bodies of water.
    Type: Grant
    Filed: February 27, 2009
    Date of Patent: July 23, 2013
    Inventor: David J. Moore
  • Patent number: 8491938
    Abstract: This invention relates to compositions comprising zinc and sulforaphane which can be used in the treatment or prevention of cancer. The invention also relates to methods of treating or preventing cancer, including prostate cancer, which comprises the administration of zinc and sulforaphane to a patient in need thereof.
    Type: Grant
    Filed: January 20, 2010
    Date of Patent: July 23, 2013
    Assignee: University of Maryland, Baltimore
    Inventor: Pei Feng
  • Publication number: 20130183277
    Abstract: Provided are compositions and methods for increasing patient CD4+ cell count while undergoing treatment for immune-mediated disease, cancer, heart disease, neurodegenerative disease, or infectious disease by administering to the patient a nutrient composition including, inter alia, alpha lipoic acid, acetyl L-carnitine, and N-acetyl-cysteine.
    Type: Application
    Filed: December 19, 2012
    Publication date: July 18, 2013
    Inventor: Jon D. Kaiser
  • Publication number: 20130177513
    Abstract: The invention relates to an extract of aerial parts of Maca rich in polyphenols, and also to a composition comprising such an extract and, where appropriate, a suitable excipient. The invention also relates to a process for extracting an extract of aerial parts of Maca rich in polyphenols, and also to the extract that can be obtained by means of said process. The invention also relates to such a composition or such an extract for use thereof in preventing or treating disorders or pathological conditions of the skin, the mucous membranes or the superficial body growths and/or for use thereof in preventing and/or treating vascular disorders. Finally, the invention relates to a cosmetic care process for the skin, the superficial body growths or the mucous membranes, with a view to improving the condition thereof or the appearance thereof, which comprises the administration of such a composition or of such an extract.
    Type: Application
    Filed: December 22, 2011
    Publication date: July 11, 2013
    Applicant: LABORATOIRES EXPANSCIENCE
    Inventors: Alex Saunois, Caroline Baudouin, Sophie Leclere-Bienfait, Sebastien Garnier, Philippe Msika
  • Patent number: 8475689
    Abstract: A topical composition containing galvanic particulates consisting of a first conductive material that is zinc and a second conductive material that is copper is provided.
    Type: Grant
    Filed: October 31, 2006
    Date of Patent: July 2, 2013
    Assignee: Johnson & Johnson Consumer Companies, Inc.
    Inventors: Ying Sun, Jue-Chen Liu, Jeffrey M. Wu, James E. Hauschild
  • Patent number: 8475850
    Abstract: Compositions and methods for enhancing heavy metal detoxification are described. The compositions and methods described provide enhanced activity of key detoxification systems including that the induction of phase II detoxification enzymes, such as glutathione S-transferases (GSTs), and NADPH quinone reductase (NQO1) activity.
    Type: Grant
    Filed: January 18, 2012
    Date of Patent: July 2, 2013
    Assignee: Metaproteomics, LLC
    Inventors: Matthew L. Tripp, Veera Konda, Amy J. Hall, Anu Desai, Jeffrey S. Bland
  • Patent number: 8466109
    Abstract: A method for reducing the formation of and/or treating skin stretchmarks is described. The method is characterized in that a composition is applied to the areas of skin liable to form or comprising stretchmarks, including skin of the thighs, abdomen, and/or breast. The applied composition includes a soya peptide, a tripeptide consisting of the amino acids glycine, histidine, and lysine, and/or mixtures of the soya peptide and tripeptide in a suitable application vehicle. The composition displays good skin tolerance.
    Type: Grant
    Filed: March 25, 2004
    Date of Patent: June 18, 2013
    Assignee: Laboratoires Expanscience
    Inventor: Philippe Msika
  • Publication number: 20130149391
    Abstract: Fluoride varnish compositions for temporary application and adhesion to a person's teeth. The composition includes a carrier comprising a resin and an adhesion promoting agent comprising an alkyl phosphoric acid. A fluoride ion source (e.g., a fluoride salt such as sodium fluoride) is dispersed within the carrier so as to provide biologically available fluoride ions to the tooth tissue being treated. The composition adheres only temporarily to tooth tissue (e.g., for a period of at least about 4 minutes, but not more than about 1 year), after which the composition spontaneously wears away as a natural result of the action of the tongue, saliva and/or other factors.
    Type: Application
    Filed: February 7, 2013
    Publication date: June 13, 2013
    Applicant: Ultradent Products, Inc.
    Inventor: Ultradent Products, Inc.
  • Publication number: 20130142869
    Abstract: The invention provides analgesic, antipyretic and anti-inflammatory compositions containing epilactose in combination with non-steroidal anti-inflammatory drugs and pharmaceutically acceptable zinc compounds. This invention relates to the use of these novel compositions for significantly improved and synergistic safety and therapeutic profiles.
    Type: Application
    Filed: December 5, 2012
    Publication date: June 6, 2013
    Inventors: Phillip Alex, Ben Johns
  • Patent number: 8454980
    Abstract: Hydrogel compositions that include an albumin/N-acetyl cysteine solution and an aqueous suspension of calcium salts or mixture of calcium and magnesium salts are described. Also described are methods of producing and using the hydrogel compositions as a support scaffold for mineralizing connective tissue replacement and repair.
    Type: Grant
    Filed: January 26, 2012
    Date of Patent: June 4, 2013
    Inventor: Stanley William Whitson
  • Patent number: 8455246
    Abstract: The present invention provides a cell culture medium formulation that supports the in vitro cultivation, particularly in suspension, of mammalian cells, particularly epithelial cells and fibroblast cells, and methods for cultivating mammalian cells in suspension in vitro using these media. The media comprise a basal medium and a polyanionic or polyanionic compound, preferably a polysulfonated or polysulfated compound, and more preferably dextran sulfate. The present invention also provides chemically defined, protein-free eukaryotic cell culture media comprising an iron chelate and zinc, which is capable of supporting the growth (and particularly the high-density growth of mammalian cells) in suspension culture, increasing the level of expression of recombinant protein in cultured cells, and/or increasing virus production in cultured cells.
    Type: Grant
    Filed: May 8, 2009
    Date of Patent: June 4, 2013
    Assignee: Life Technologies Corporation
    Inventors: Stephen Gorfien, Richard Fike, Glenn Godwin, Joyce Dzimian, David A. Epstein, Dale Gruber, Paul Price
  • Publication number: 20130136803
    Abstract: The present invention provides a composition for treating recirculating or stagnant water. The composition contains a phosphorus-containing compound, which is metaphosphate compound, a polyphosphoric acid or a polyphosphate, and one or more zinc compounds. The phosphorus-containing compound is a compound which is not readily hydrolyzable to an orthophosphate. In another aspect of the present invention, provided is a method of controlling algae in a body of recirculating or stagnant water using the composition.
    Type: Application
    Filed: November 29, 2012
    Publication date: May 30, 2013
    Applicant: ARCH CHEMICALS, INC.
    Inventor: ARCH CHEMICALS, INC.
  • Publication number: 20130129787
    Abstract: Described herein is the synthesis of adhesive complex coacervates from electrostatically associated block copolymers, wherein the block copolymers comprise alternating polycationic and polyanionic blocks. Methods for making and the using the adhesive complex coacervates are also described herein.
    Type: Application
    Filed: February 25, 2011
    Publication date: May 23, 2013
    Inventor: Russell J. Stewart
  • Patent number: 8440227
    Abstract: A biological adhesive formulation comprising dextrin, at least one adhesiveness modifier agent, and at least one antibiotic is suitable for promoting healing of tissue in a patient, for example, to prevent anastomosis of a surgical wound in the digestive system of a patient, and for affixing prosthesis during a hernia operation in a patient and occluding a fistula within a patient.
    Type: Grant
    Filed: April 23, 2012
    Date of Patent: May 14, 2013
    Inventor: Jorge Cueto-Garcia
  • Patent number: 8440230
    Abstract: The present invention is related to a formulation based on micronized natural calcite mineral consisting of: A. mineral part which is characterized: (i) by the particle size with diameter smaller than 5 ?m, where the distribution of particle size is such that minimum of 10% of particles are with diameter under 900 nm, with total surface of particles greater than 3.2 m2/g, and with total porous volume greater than 0.012 cm3/g, and by composition: (ii) CaCO3, MgCO3, FeCO3, MnCO3, ZnCO3 and SiO2 in mixtures where CaCO3 is presented in amount from 10% to 99% of mineral part; and B. adjuvant selected from the group consisting of: wetting agent, drift-control agent at application by spraying, humic acid salt, amino-acids salts, complex of plant micro-nutrients, vitamin, plant hormone, nitrogen fertilizer, potassium salt, borate salt, molybdate salt, plant extract, chlorophyll, yeast extract, or mixture of these substances; where A. and B. form an aqueous suspension wherein percentage of A. and B.
    Type: Grant
    Filed: January 29, 2008
    Date of Patent: May 14, 2013
    Assignee: Mikro Mineral USA, Inc.
    Inventors: Antonio Lelas, Ivica Cepanec
  • Patent number: 8440212
    Abstract: The present invention relates to treatment of water, and more specifically to treatment of water using a stable formulation of polyhexamethylene biguanide (PHMB) and a liquid or solid zinc salt for the application and prevention algae in recirculated and stagnant water systems. The invention also encompasses methods of treating water that already contains PHMB.
    Type: Grant
    Filed: August 5, 2010
    Date of Patent: May 14, 2013
    Assignee: Arch Chemicals, Inc.
    Inventors: Michael J. Unhoch, Patricia Brown
  • Publication number: 20130101678
    Abstract: The present invention generally relates to methods and compositions for treating pathogenic vaginal biofilms. More specifically, the invention relates to pharmaceutical compositions comprising a combination of boric acid and diethylaminetetracetic acid (EDTA) and to methods of using such compositions to treat or prevent biofilm formation associated with vaginal infections, such as bacterial vaginosis (BV), vulvovaginal candidiasis (VVC), trichomoniasis or mixed infections.
    Type: Application
    Filed: December 10, 2012
    Publication date: April 25, 2013
    Applicant: TOLTEC PHARMACEUTICALS, LLC
    Inventor: Toltec Pharmaceuticals, LLC
  • Publication number: 20130091611
    Abstract: The present invention provides the use of nanoparticles of a compound of general formula MnXy, where M is (i) a metal selected from the group consisting of Calcium (Ca), Aluminium (Al), Zinc (Zn), Nickel (Ni), Tungsten (W) or Copper (Cu); or (ii) a non-metal selected from the group consisting of Silicon (Si), Boron (B) or Carbon (C); in which n is equal to 1, 2, or 3, and X is (iii) a non-metal selected from the group consisting of Oxygen (O), Nitrogen (N), or Carbon (C); or (iv) an anion selected from the group consisting of phosphate (PO43?), hydrogen phosphate (HPO42?), dihydrogen phosphate (H2PO4?), carbonate (CO3), silicate (SiO42?), sulphate (SO42?), nitrate (NO3?), nitrite (NO2?); in which y is equal to 0, 1, 2, 3 or 4; for use in reducing and/or preventing virus transmission. Articles of protective clothing or filters are provided in which the fibres are coated with said nanoparticles for use in reducing and/or preventing virus transmission.
    Type: Application
    Filed: November 30, 2012
    Publication date: April 18, 2013
    Inventors: Guogang Ren, John S. Oxford, Prof., Paul William Reip, Robert Lambkin-Williams, Alexander Mann
  • Publication number: 20130084272
    Abstract: The present invention relates to compositions, kits and methods for the administration of compositions and kits for supplementation with twelve carbon chain fatty acids or twelve carbon chain acylglycerols; and specifically for the supplementation with twelve carbon chain fatty acids such as lauric acid and twelve carbon chain acylglycerols such as monolaurin; and specifically for the co-supplementation with other vitamins, minerals and nutrients.
    Type: Application
    Filed: September 29, 2011
    Publication date: April 4, 2013
    Inventors: Philippe PERRIN, Guillaume HERRY, Cecile BOYER-JOUBERT
  • Patent number: 8409598
    Abstract: It is an object of the present invention to provide a copper ion-producing composition that has a copper ion (mineral)-based germicidal activity against Legionella spp., Escherichia coli, Staphylococcus aureus, and saprophytic bacteria occurring in the water in drinking water storage tanks, hot springs, bathhouses, and pools, and that can supply mineral, and also to provide a granular composition that contains this copper ion-producing composition. The copper ion-producing composition is obtained by mixing 0.3 to 10 weight parts surfactant with 100 weight parts metallic copper powder. The granular composition is obtained by kneading this copper ion-producing composition with poorly water-soluble material that has a softening point of not less than 70° C. The granular composition is also obtained by coating the copper ion-producing composition on the surface of poorly water-soluble material that has a softening point of not less than 70° C.
    Type: Grant
    Filed: March 10, 2006
    Date of Patent: April 2, 2013
    Inventor: Iwao Hishida